| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3191127 | Annals of Allergy, Asthma & Immunology | 2013 | 7 Pages |
Abstract
Although two-thirds of patients filled a prescription for an epinephrine autoinjector after an ED visit or hospitalization for SIA, only 14% of patients received follow-up care by an allergist/immunologist. This missed opportunity to provide venom immunotherapy, an essentially curative therapy, unnecessarily places patients at risk for recurrent anaphylaxis.
Related Topics
Health Sciences
Medicine and Dentistry
Dermatology
Authors
Susan A. MD, Sunday MPH, ScD, Wenhui PhD, MS, MBA, Carlos A. MD, DrPH,